We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.Common Contracts
5 similar Employee Severance Agreement contracts by Protagonist Therapeutics, Inc
EMPLOYEE SEVERANCE AGREEMENTEmployee Severance Agreement • August 1st, 2016 • Protagonist Therapeutics, Inc • Pharmaceutical preparations • California
THIS EMPLOYEE SEVERANCE AGREEMENT (this “Agreement”) is entered into as of the 1st day of August, 2016, by and between Protagonist Therapeutics, Inc., a Delaware corporation (the “Company”), and William Hodder (the “Employee”).
Standard Contracts
EMPLOYEE SEVERANCE AGREEMENTEmployee Severance Agreement • August 1st, 2016 • Protagonist Therapeutics, Inc • Pharmaceutical preparations • California
THIS EMPLOYEE SEVERANCE AGREEMENT (this “Agreement”) is entered into as of the 1st day of August, 2016, by and between Protagonist Therapeutics, Inc., a Delaware corporation (the “Company”), and David Y. Liu, Ph.D. (the “Employee”).
EMPLOYEE SEVERANCE AGREEMENTEmployee Severance Agreement • August 1st, 2016 • Protagonist Therapeutics, Inc • Pharmaceutical preparations • California
THIS EMPLOYEE SEVERANCE AGREEMENT (this “Agreement”) is entered into as of the 1st day of August, 2016, by and between Protagonist Therapeutics, Inc., a Delaware corporation (the “Company”), and Richard S. Shames, M.D. (the “Employee”).
EMPLOYEE SEVERANCE AGREEMENTEmployee Severance Agreement • August 1st, 2016 • Protagonist Therapeutics, Inc • Pharmaceutical preparations • California
THIS EMPLOYEE SEVERANCE AGREEMENT (this “Agreement”) is entered into as of the 1st day of August, 2016, by and between Protagonist Therapeutics, Inc., a Delaware corporation (the “Company”), and Dinesh V. Patel, Ph.D. (the “Employee”).
EMPLOYEE SEVERANCE AGREEMENTEmployee Severance Agreement • August 1st, 2016 • Protagonist Therapeutics, Inc • Pharmaceutical preparations • California
THIS EMPLOYEE SEVERANCE AGREEMENT (this “Agreement”) is entered into as of the 1st day of August, 2016, by and between Protagonist Therapeutics, Inc., a Delaware corporation (the “Company”), and Thomas P. O’Neil (the “Employee”).